Layered self-assemblies for controlled drug delivery: A translational overview.
Apoorva Sarode1, Akshaya Annapragada2, Junling Guo3
1John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, USA; Wyss Institute of Biologically Inspired Engineering at Harvard University, Boston, MA 02115, USA.
Layer-by-layer (LbL) deposition and other self-assembly techniques offer tunable, multifunctional systems for advanced drug delivery. Innovations are addressing scalability challenges for commercial translation of these smart drug carriers.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Self-assembly, a natural phenomenon, inspires the development of functional materials for biomedical applications.
- Layered self-assembled systems offer tunability and multifunctionality essential for controlled and targeted drug release.
- Layer-by-layer (LbL) deposition is a key technique for creating tailored layered self-assemblies.
Purpose of the Study:
- To review drug delivery applications utilizing Layer-by-layer (LbL) deposition.
- To discuss scalability challenges and technological innovations for LbL deposition.
- To explore alternative self-assembly techniques like metal-phenolic networks (MPNs) and Liesegang rings for drug delivery.
Main Methods:
- Review of literature on Layer-by-layer (LbL) deposition for drug delivery.
- Analysis of scalability challenges and innovations in self-assembly techniques.
- Examination of metal-phenolic networks (MPNs) and Liesegang rings for controlled drug release.
Main Results:
- Layer-by-layer (LbL) deposition is a versatile technique for creating tunable, multifunctional drug delivery systems.
- Scalability remains a challenge for commercial translation, but technological innovations are emerging.
- Alternative methods like MPNs and Liesegang rings show promise for controlled drug delivery.
Conclusions:
- Self-assembly phenomena, combined with material science advances, can yield powerful, scalable smart drug carriers.
- Further development is needed to overcome scalability hurdles for widespread clinical application of LbL and similar techniques.
- The integration of various self-assembly strategies holds significant potential for next-generation therapeutics.
More Related Videos
10:01Directed Assembly of Elastin-like Proteins into defined Supramolecular Structures and Cargo Encapsulation In Vitro
Published on: April 8, 2020
05:08Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
Published on: September 20, 2017
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Cellular Membranes and Drug Transport
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Biopharmaceutics and Pharmacokinetics: Overview
